Dr Graeme John Finlay

MSc (Hons) PhD BTh

Research | Current

Research group

Teaching | Current

Course Director, MEDSCI 203, Mechanisms of Disease

Course Director, MEDSCI 101G, Environmental Threats to Human Health

Selected publications and creative works (Research Outputs)

  • Chen, Y. Y., Finlay, G. J., Kirker, J. A., Marshall, E. S., Richardson, E., & Baguley, B. C. (2011). In vivo and in vitro assessment of the action of SN 28049, a benzonaphthyridine derivative targeting topoisomerase II, on the murine Colon 38 carcinoma. INVESTIGATIONAL NEW DRUGS, 29 (6), 1504-1510. 10.1007/s10637-010-9509-0
    URL: http://hdl.handle.net/2292/17458
  • Drummond, C. J., Finlay, G. J., Broome, L., Marshall, E. S., Richardson, E., & Baguley, B. C. (2010). Action of SN 28049, a new DNA binding topoisomerase II-directed antitumour drug: comparison with doxorubicin and etoposide. Investigational New Drugs, 1-9.
    URL: http://hdl.handle.net/2292/15811
  • Bridewell, D. J. A., Porter, A. C. G., Finlay, G. J., & Baguley, B. C. (2008). The role of topoisomerases and RNA transcription in the action of the antitumour benzonaphthyridine derivative SN 28049. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 62 (5), 753-762. 10.1007/s00280-007-0660-z
    URL: http://hdl.handle.net/2292/17456

Contact details

Primary office location

M&HS BUILDING 504 - Bldg 504
Level 0, Room 018
New Zealand